Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 87 clinical trials
featured
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

  • 86 views
  • 25 Mar, 2021
  • 1 location
featured
TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis

TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis

  • 118 views
  • 23 Nov, 2020
  • 1 location
featured
  • 80 views
  • 25 Mar, 2021
  • 1 location
Safety Tolerability and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis

The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

fibrosis
platelet count
cilofexor
  • 83 views
  • 10 May, 2021
  • 223 locations
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)

cholangitis (PSC) for daily intake of 40 mg simvastatin/placebo for 5 years. The aim is to study effect of prognosis of PSC by long term intake of simvastatin. Outcome measures are death, liver

  • 0 views
  • 27 Jan, 2021
  • 11 locations
Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

Protection of Oddi's sphincter remains a huge argument especially in the long term complications like common bile duct stone recurrence or cholangitis after ERCP, which determined to destroy the

  • 0 views
  • 01 Mar, 2021
  • 13 locations
Linerixibat Long-term Safety and Tolerability Study

biliary cholangitis (PBC) who participated in a prior eligible clinical trial with linerixibat. Participants will be administered with 90 milligrams (mg) linerixibat orally twice daily. The total daily

cholestatic pruritus
cholangitis
  • 0 views
  • 21 Mar, 2021
  • 22 locations
Vancomycin for Primary Sclerosing Cholangitis

To find out if vancomycin is a safe and effective therapy for primary sclerosing cholangitis. Funding Source - FDA OOPD

obstruction
prednisone
MRI
liver disease
biliary obstruction
  • 27 views
  • 24 Jan, 2021
  • 4 locations
A Pilot Study Examining Diet in Primary Sclerosing Cholangitis

This research study is exploring the effects of dietary intervention in PSC. Study participants will be randomly assigned to either the Specific Carbohydrate Diet (SCD) or a vegan/low-sulfur diet for 8 weeks; the entire study will last approximately 14 weeks. Participants will work with BWH Registered Dieticians and receive dietary …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis

To assess the efficacy of mindfulness-based intervention (MBI) intervention in the treatment of moderate or severe fatigue in patients with primary biliary cholangitis (PBC).

fatigue
cirrhosis
ursodiol
cholangitis
  • 1 views
  • 17 Feb, 2021
  • 1 location